Danielle Erin Jackson , FNP
Nurse Practitioner - Primary Care • Clovis, CA
2131 Herndon Ave Ste 103
Clovis, CA 936116304
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Danielle Jackson is listed in NPPES under Nurse Practitioner - Primary Care.
-
NPI assigned on June 2, 2021; this date does not establish years in practice.
-
Published CMS data list 891 Medicare Part D prescriptions, including refills, in 2023.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023. Published rows only; this is not a quality measure.
-
Published Part D records, 2023:
- Gabapentin — 73 prescription fills, including refills.
- Levothyroxine Sodium — 64 prescription fills, including refills.
- Atorvastatin Calcium — 62 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 30 records in the table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part D prescriptions went from 2,085 in 2022 to 891 in 2023.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2022–2023.
Practice Location & Contact Primary Location
2131 Herndon Ave Ste 103
Clovis, CA 936116304
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Nurse Practitioner - Primary Care: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
1,978 standardized 30-day fills in 2023
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$71,045 in 2023
The total cost of these prescriptions in 2023, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023.
Open Payments general payments, program year 2025
All general payments: $2,963.93 across 148 records.
By nature of payment
- Food and Beverage: $2,963.93 across 148 records.
Reporting-company totals (3 largest of 17)
- AstraZeneca Pharmaceuticals LP: $616.54 across 18 records.
- ABBVIE INC.: $562.04 across 37 records.
- Aimmune Therapeutics, Inc.: $287.46 across 26 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2021
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Clovis and California
Billing and prescribing volume is not a quality rating.
Medicare Part D
Comparisons use 2024 data. The latest CMS data for Danielle Jackson are from 2023.
4 active clinicians are listed under Nurse Practitioner - Primary Care with a practice address in Clovis, CA (1,134 in California).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 57% from 2,085 in 2022 to 891 in 2023.
- 2022: 2,085
- 2023: 891
-
30-day fills
30-day fills decreased 48% from 3,768 in 2022 to 1,978 in 2023.
- 2022: 3,768
- 2023: 1,978
-
Part D drug cost
Part D drug cost decreased 68% from $221,721 in 2022 to $71,045 in 2023.
- 2022: $221,721
- 2023: $71,045
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $124.99 in 2021 to $2,963.93 in 2025.
- 2021: $124.99
- 2022: $256.63
- 2023: $3,626.05
- 2024: $5,609.99
- 2025: $2,963.93
Sources: CMS Medicare Part D Prescribers (2023), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 148 records totaling $2,963.93.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
Repatha | General | $125.00 |
| Phathom Pharmaceuticals, Inc. |
Food and Beverage
Cash or cash equivalent
|
VOQUEZNA | General | $125.00 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $124.99 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $124.99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC |
Food and Beverage
In-kind items and services
|
XIFAXAN | General | $124.87 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $121.82 |
| Madrigal Pharmaceuticals |
Food and Beverage
In-kind items and services
|
REZDIFFRA | General | $121.06 |
| Eli Lilly and Company |
Food and Beverage
Cash or cash equivalent
|
MOUNJARO | General | $111.15 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $37.37 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $30.62 |
| Madrigal Pharmaceuticals |
Food and Beverage
In-kind items and services
|
REZDIFFRA | General | $30.60 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $29.93 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $29.14 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $28.14 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $28.10 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
UBRELVY | General | $27.34 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $27.09 |
| Aimmune Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
ZENPEP | General | $26.72 |
| Madrigal Pharmaceuticals |
Food and Beverage
In-kind items and services
|
REZDIFFRA | General | $25.71 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SYNTHROID | General | $25.42 |
| Madrigal Pharmaceuticals |
Food and Beverage
In-kind items and services
|
REZDIFFRA | General | $24.74 |
| HOLOGIC INC |
Food and Beverage
In-kind items and services
|
APTIMA | General | $24.11 |
| Ardelyx, Inc. |
Food and Beverage
In-kind items and services
|
IBSRELA | General | $24.04 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $23.99 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $23.84 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2023.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Gabapentin | Gabapentin | 73 | 3,985 | $2,187.80 | 28 |
| Levothyroxine Sodium | Levothyroxine Sodium | 64 | 4,435 | $1,241.39 | 29 |
| Atorvastatin Calcium | Atorvastatin Calcium | 62 | 5,486 | $1,790.38 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 53 | 4,050 | $517.70 | 19 |
| Lisinopril | Lisinopril | 51 | 3,840 | $888.95 | 22 |
| Metformin Hcl | Metformin Hcl | 51 | 4,240 | $1,049.02 | 27 |
| Amlodipine Besylate | Amlodipine Besylate | 45 | 3,859 | $1,235.47 | 23 |
| Losartan Potassium | Losartan Potassium | 42 | 2,930 | $887.13 | 20 |
| Trulicity | Dulaglutide | 34 | 1,282 | $46,622.61 | 13 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 33 | 2,770 | $1,909.99 | 16 |
| Omeprazole | Omeprazole | 31 | 2,310 | $986.90 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 31 | 1,059 | $1,684.61 | — |
| Ibuprofen | Ibuprofen | 28 | 800 | $243.58 | 11 |
| Pantoprazole Sodium | Pantoprazole Sodium | 28 | 2,100 | $896.66 | 12 |
| Furosemide | Furosemide | 25 | 1,710 | $185.61 | 12 |
| Baclofen | Baclofen | 24 | 859 | $850.38 | — |
| Ventolin Hfa | Albuterol Sulfate | 24 | 654 | $1,670.90 | — |
| Trazodone Hcl | Trazodone Hcl | 22 | 1,140 | $529.20 | — |
| Metoprolol Tartrate | Metoprolol Tartrate | 19 | 1,710 | $433.22 | — |
| Simvastatin | Simvastatin | 18 | 1,200 | $442.92 | — |
| Metoprolol Succinate | Metoprolol Succinate | 18 | 1,440 | $426.64 | — |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | 1,170 | $914.40 | — |
| Carvedilol | Carvedilol | 14 | 846 | $347.96 | — |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 14 | 520 | $236.78 | — |
| Diclofenac Sodium | Diclofenac Sodium | 14 | 517 | $499.62 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2023; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2021-06-02NUCC Taxonomy Code: 363LP2300X
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Family Medicine
Doctor of Osteopathic Medicine (D.O.)
Nurse Practitioner - Family
Nurse Practitioner
Nurse Practitioner - Family
Family Nurse Practitioner (Board Certified)
Career & Practice History
NPI enumerated June 02, 2021.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from June 2021 to August 2026.
NPI Administrative Meta
Mailing Address
2131 Herndon Ave Ste 103
Clovis, CA 936116304
Phone: 5594839911